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surgeryFig. 1. Geographic representation of facial palsy survey conducted across the United
Kingdom.Dear Sir,
Facial palsy (FP) remains a reconstructive challenge for head
and neck surgeons, with an annual incidence of 70/100,000 in
the UK. Approximately 127,000 of these paralyses become chronic
(>2 years duration).1 The underlying aetiology varies and clinical
presentations are diverse.2 Gold standard management requires a
multidisciplinary approach, including treatment of the underlying
cause and adjunctive physical and psychological therapies. Oper-
ative interventions for chronic facial palsy often involve dynamic
facial reanimation (e.g. cross-facial nerve grafting and micro-
neurovascular muscle transfer) and the use of static techniques
to improve facial symmetry, such as eyelid weights and facial sus-
pensions.3,4 Botulinum toxin injection is used increasingly for
facial symmetrisation and to counteract synkinesis in the acute
and chronic phases, particularly in cases where surgery is not
appropriate.3 Although these current treatment modalities have
demonstrated favourable long-term results and signiﬁcant im-
provements in patients’ quality of life, FP service provision is
not uniform across the UK, leaving some patients receiving no
treatment whatsoever. Often, this is because funding for FP care
has been refused by local commissioning bodies due to their
incorrect identiﬁcation of FP procedures as being purely
cosmetic.5
To assess this “postcode lottery” in FP service access, we con-
ducted a structured survey of 24 consultant plastic surgeons within
the BAPRAS Facial Palsy Special Interest Group via email correspon-
dence and telephone interviews. The survey involved three ques-
tions: i) Do you have funding permission to perform facial
reanimation surgery, blepharoplasty, facial suspension, unilateral
facelift or brow lift and botulinum toxin injections, without having
to request commissioning panel prior approval; ii) approximately
howmany facial palsy procedures does your unit perform annually;
and, iii) are there any local funding restraints on performing any of
these procedures?
The mean estimated number of reconstructions and botuli-
num toxin injections performed per annum were 43 (range:Elsevier Ltd on behalf of Surgicaland 52 (range: 12e200) respectively. Seventeen plastic
units currently require no permission to perform surgi-
cal procedures for facial palsy. Five units require funding
permission prior to blepharoplasty, face-lifts or brow-lifts
(Fig. 1). Two large specialist centres must seek prior permission
from their commissioning body for any FP procedures on a case-
by-case basis.
This survey demonstrates the variability in FP service provision
within one surgical specialty in the UK. This directly affects patient
care. In light of the recent change to local clinical commissioning
groups (CCGs), now is the time to assist GP network leaders and
highlight the importance of Facial Palsy specialist treatment, with
the aim of creating equality in service provision across all UK
regions.Associates Ltd.
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